Oncogene - Table of Contents alert Volume 33 Issue 14

If you are unable to see the message below, click here to view.

Advertisement BLUEPRINT quality antibodies you can TRUST. Partnering with epigenetics experts in the BLUEPRINT Epigenome consortium, Diagenode has developed completely validated epigenetics antibodies with the highest specificity and sensitivity available. Achieve unparalleled MeDIP, ChIP, and ChIP-seq results with validated antibodies you can trust. Learn more. TABLE OF CONTENTS Volume 33, Issue 14 (April 2014) In this issue Reviews Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Does your manuscript have what it takes to get published? Macmillan Science Communication Scientific Editing can help you maximize the impact of your research or grant application with in-depth developmental editing and incisive advice from Nature-standard editors.  Submit your manuscript today!    Reviews Top Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment A Casazza, G Di Conza, M Wenes, V Finisguerra, S Deschoemaeker and M Mazzone Oncogene 2014 33: 1743-1754; advance online publication, April 22, 2013; 10.1038/onc.2013.121 Abstract | Full Text Multilayer control of the EMT master regulators H Zheng and Y Kang Oncogene 2014 33: 1755-1763; advance online publication, April 22, 2013; 10.1038/onc.2013.128 Abstract | Full Text Original Articles Top Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity J Viotti, E Duplan, C Caillava, J Condat, T Goiran, C Giordano, Y Marie, A Idbaih, J-Y Delattre, J Honnorat, F Checler and C Alves da Costa Oncogene 2014 33: 1764-1775; advance online publication, May 6, 2013; 10.1038/onc.2013.124 Abstract | Full Text Loss of TSC2 confers resistance to ceramide and nutrient deprivation G G Guenther, G Liu, M U Ramirez, R J McMonigle, S M Kim, A N McCracken, Y Joo, I Ushach, N L Nguyen and A L Edinger Oncogene 2014 33: 1776-1787; advance online publication, April 22, 2013; 10.1038/onc.2013.139 Abstract | Full Text Met-induced membrane blebbing leads to amoeboid cell motility and invasion A Laser-Azogui, T Diamant-Levi, S Israeli, Y Roytman and I Tsarfaty Oncogene 2014 33: 1788-1798; advance online publication, May 13, 2013; 10.1038/onc.2013.138 Abstract | Full Text Heparanase promotes lymphangiogenesis and tumor invasion in pancreatic neuroendocrine tumors K E Hunter, C Palermo, J C Kester, K Simpson, J-P Li, L H Tang, D S Klimstra, I Vlodavsky and J A Joyce Oncogene 2014 33: 1799-1808; advance online publication, May 6, 2013; 10.1038/onc.2013.142 Abstract | Full Text Theileria induces oxidative stress and HIF1α activation that are essential for host leukocyte transformation S Medjkane, M Perichon, J Marsolier, J Dairou and J B Weitzman Oncogene 2014 33: 1809-1817; advance online publication, May 13, 2013; 10.1038/onc.2013.134 Abstract | Full Text RRP1B is a metastasis modifier that regulates the expression of alternative mRNA isoforms through interactions with SRSF1 M Lee, A M Dworkin, D Gildea, N S Trivedi, NISC Comparative Sequencing Program, G B Moorhead and N P S Crawford Oncogene 2014 33: 1818-1827; advance online publication, April 22, 2013; 10.1038/onc.2013.133 Abstract | Full Text ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer Q Ye, W Cai, Y Zheng, B M Evers and Q-B She Oncogene 2014 33: 1828-1839; advance online publication, April 29, 2013; 10.1038/onc.2013.122 Abstract | Full Text Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms P Tripathi, Y Wang, M Coussens, K R Manda, A M Casey, C Lin, E Poyo, J D Pfeifer, N Basappa, C M Bates, L Ma, H Zhang, M Pan, L Ding and F Chen Oncogene 2014 33: 1840-1849; advance online publication, April 29, 2013; 10.1038/onc.2013.132 Abstract | Full Text MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines A Vultur, J Villanueva, C Krepler, G Rajan, Q Chen, M Xiao, L Li, P A Gimotty, M Wilson, J Hayden, F Keeney, K L Nathanson and M Herlyn Oncogene 2014 33: 1850-1861; advance online publication, April 29, 2013; 10.1038/onc.2013.131 Abstract | Full Text Overexpression of Cdk6 and Ccnd1 in chondrocytes inhibited chondrocyte maturation and caused p53-dependent apoptosis without enhancing proliferation K Ito, Z Maruyama, A Sakai, S Izumi, T Moriishi, C A Yoshida, T Miyazaki, H Komori, K Takada, H Kawaguchi and T Komori Oncogene 2014 33: 1862-1871; advance online publication, April 29, 2013; 10.1038/onc.2013.130 Abstract | Full Text Short Communication Top Genome-wide functional screening identifies CDC37 as a crucial HSP90-cofactor for KIT oncogenic expression in gastrointestinal stromal tumors A Mariño-Enríquez, W-B Ou, G Cowley, B Luo, A H Jonker, M Mayeda, M Okamoto, G Eilers, J T Czaplinski, E Sicinska, Y Wang, T Taguchi, G D Demetri, D E Root and J A Fletcher Oncogene 2014 33: 1872-1876; advance online publication, April 15, 2013; 10.1038/onc.2013.127 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.